These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported Terminated 2004-004620-12 Assessment of normal release morphine in the management of dyspnoea 2006-12-07 due-trials
Listed as ongoing, but also has a completion date 2004-004707-38 A multicentre randomised phase II clinical trial comparing oxaliplatin (Eloxatin), capecitabine (Xeloda) and pre-operative radiotherapy with or without cetuximab followed by total mesorectal excision ... 2016-07-20 bad-data
Reported results 2005-001660-31 A Prospective Randomized Controlled Trial of Morphine versus Oxycodone for Cancer Pain: Genetic Determinants of Response to Opioids. 2012-02-07 due-trials
Exempt, with results Terminated 2005-002027-13 A phase I/II study of docetaxel plus prednisolone plus diethylstilbestrol plus aspirin in androgen-independent prostate cancer 2007-08-17 not-yet-due
Exempt, with results 2005-002715-24 TARGET Trial: A Phase I-II dose finding and early efficacy study of combination therapy with erlotinib (tarceva), gemcitabine, bevacizumab (avastin) and capecitabine in advanced pancreatic cancer. 2011-09-01 not-yet-due
Reported results 2005-002736-10 Open, Randomised Phase II Study Assessing The Toxicity And Efficacy Of Platinum-Based Chemotherapy With Vitamin Supplementation In The Treatment Of Lung Cancer 2012-11-09 due-trials
Exempt, with results 2005-002801-22 Carboplatin Plus Xeloda Followed By Maintenance Xeloda (CARBOX) 2010-04-23 not-yet-due
Reported results Terminated 2005-003795-37 Response to Parenteral Morphine and Oxycodone in Acute Pain. 2009-03-01 due-trials
Reported results 2005-004505-29 Phase II clinical trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with previously untreated unresectable liver-only metastases from colorectal cancer 2015-02-10 due-trials
Reported results 2005-006018-16 A Randomised Phase III Trial Of Low Dose DailyDexamethasone Versus Intermittent Dexamethasone Versus Prednisolone In Hormone Refractory Prostate Cancer 2011-05-26 due-trials
Completed, but no date Terminated 2006-000492-16 A Phase II, Single-Centre, Randomised, Controlled, Open-Label Clinical Trial to Compare the Efficacy and Safety of Three Therapeutic Interventions on the Treatment of Hypothalamic Obesity due to Child... bad-data
Reported results 2006-000810-18 A Randomised Study to Investigate the Effectiveness of Acupuncture for the Relief of Dyspnoea in Patients with Non-Small Cell Lung Cancer 2014-03-06 due-trials
Reported results Terminated 2006-003844-41 Feasibility study of R-CHOP plus bevacizumab in patients with diffuse large B cell lymphoma (DLBCL) 2010-06-15 due-trials
Reported results 2006-004282-34 A phase II study of bethanechol chloride to treat pseudomembranous candidosis in cancer patients with salivary gland dysfunction. 2010-09-01 due-trials
Exempt, with results Terminated 2006-004822-97 A Phase I / II Trial to Evaluate the Combination of Infliximab and Sorafenib in the Treatment of Renal Cell Carcinoma 2009-09-14 not-yet-due
Reported results Terminated 2006-006073-24 CINATRA: Chromosomal Instability and Anti-Tubulin Response Assessment: A Phase II Study of Epothilone B in Metastatic Colon Carcinoma in patients with Microsatellite Instability or Chromosomal Instabi... 2011-04-11 due-trials
Reported results Terminated 2006-006615-80 A Pilot Study in Metastatic Advanced Thyroid Cancer Evaluating the Safety and Efficacy of Sorafenib 2011-08-11 due-trials
Other 2007-003877-21 Trial of Perioperative Endocrine Therapy - Individualising Care (POETIC) not-yet-due
Reported results 2007-005976-15 A randomised open-labelled multicentre trial of the efficacy of epirubicin, oxaliplatin and capecitabine (EOX) with or without panitumumab in previously untreated advanced oesophago-gastric cancer (RE... 2014-02-28 due-trials
Reported results Terminated 2008-000517-30 A multicentre randomised phase II clinical study of UFT/leucovorin (LV), radiotherapy with or without cetuximab following induction gemcitabine plus capecitabine in patients with locally advanced panc... 2014-12-08 due-trials
Not reported Terminated 2008-000524-82 MESH: A Non-Randomised Phase II Trial of Methotrexate in Metastatic Colorectal Cancer with MSH2 Deficiency 2012-04-16 due-trials
Reported results 2008-004499-38 A randomised double-blind placebo-controlled trial of the safety and efficacy of ethosuximide 250mg capsules for the management of chemotherapy-induced painful peripheral neuropathy. 2014-07-09 due-trials
Exempt, with results 2008-008676-13 A Phase II Study Of Sunitinib And Low Dose Metronomic Cyclophosphamide In Advanced Renal Cell Cancer 2015-07-24 not-yet-due
Reported results 2009-012945-49 A Phase II Trial of Nilotinib in the Treatment of Patients with c-KIT Mutated Advanced Acral and Mucosal Melanoma (NICAM) 2016-12-12 due-trials
Other 2010-021163-33 A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma (CASPS) Ensayo fase II de Cediranib en el tratamiento de pacientes con sarcoma de partes blandas alveolar ... not-yet-due
Reported results 2010-021412-42 Prospective randomised controlled trial to investigate the effectiveness of inhalers for the relief of breathlessness in patients with lung cancer and COPD 2016-09-30 due-trials
Reported results Terminated 2010-022416-40 A Translational, proof of the concept, study Of Pre-operative Pazopanib in treatment-naive patients with resectable soft tissue Sarcomas (TOPPS) 2013-04-25 due-trials
Other 2011-000601-49 TOPARP: Phase II Trial of Olaparib in Patients with Advanced Castration Resistant Prostate Cancer. not-yet-due
Reported results 2011-001793-26 A Phase II Trial of Metformin and Axitinib in BRAF Mutated Advanced Melanoma 2015-07-29 due-trials
Reported results 2011-003718-18 Proof-of-concept study of AZD 4547 in patients with FGFR1 or FGFR2 amplified tumours 2017-11-30 due-trials
Other 2011-004146-18 Cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) versus gemcitabine, cisplatin and methyl prednisolone (GEM-P) in the first line treatment Of T-cell Lymphoma, a multicentre randomis... not-yet-due
Other 2011-004562-16 A Phase II Study of Axitinib in Patients with Metastatic Renal Cell Cancer Unsuitable for Nephrectomy not-yet-due
Other 2012-002620-32 A randomised phase II study comparing LEnalidomide plus rituximab, GEmcitabine and methylprednisolone (LR-GEM) to rituximab, gemcitabine, methylprednisolone and cisplatiN (R-GEM-P) in second-line trea... not-yet-due
Exempt, with results 2012-003896-20 TAX-TORC: A Phase I multi-centre trial of the combination of AZD2014 (dual TORC1 and TORC2 inhibitor) and weekly paclitaxel in patients with solid tumours 2017-11-15 not-yet-due
Reported results 2012-004211-31 Randomised double-blind controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline (PTX) in patients suffering long-term adverse effects of radiotherapy for pelvic cancer 2019-12-19 due-trials
Other 2013-000293-29 A prospective, multi-centre, open label, non-randomised two stage phase II clinical trial evaluating the efficacy of abiraterone in patients with epithelial ovarian (including fallopian tube and prima... not-yet-due
Other 2013-001949-13 An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin plus 5-fluorouracil versus Carboplatin plus Weekly Paclitaxel in Patients with Inoperable Loc... not-yet-due
Other 2013-004055-20 A phase II randomised trial of biomarkers to assess (dose-) response in patients with metastatic castration resistant prostate cancer treated with radium-223. not-yet-due
Exempt, with results 2013-004091-34 A randomised Phase II study of Enzalutamide (MDV3100) in combination with AZD5363 in Patients with Metastatic Castration - Resistant Prostate Cancer not-yet-due
Not reported Terminated 2014-000845-64 A multicentre randomised phase II study of aflibercept plus chemotherapy in patients with colorectal liver-only metastases deemed to be inoperable or unsuitable for upfront liver resection 2015-03-10 due-trials
Reported results 2014-000887-16 A phase II randomised study evaluating the biological and clinical effects of the combination of palbociclib with letrozole as neoadjuvant therapy in post-menopausal women with ER+ primary breast canc... 2020-03-03 due-trials
Other 2014-001470-34 Pilot institutional study evaluating 5-fluorouracil following radiation therapy in children and young adults with relapsed/refractory ependymoma. not-yet-due
Other 2014-002169-30 Planning treatment for oesophago-gastric cancer: a randomised maintenance therapy trial (PLATFORM Trial) not-yet-due
Reported results 2014-003319-12 Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO) 2019-04-23 due-trials
Other 2014-004065-25 Randomised Phase II Trial of Pembrolizumab and Radiotherapy in Melanoma not-yet-due
Reported results Terminated 2014-005684-32 [18F] DIHYDRO-TESTOSTERONE PET IMAGING IN PATIENTS WITH PROGRESSIVE PROSTATE CANCER 2018-09-15 due-trials
Not reported Terminated 2015-001605-14 A Randomised, double-blind, placebo controlled, multi-centre phase II study to assess the Efficacy and safety of 2nd line Olaparib in combination with Paclitaxel, in Western patients with advanced gas... 2016-05-23 due-trials
Other 2015-003009-40 Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker to Stratify Management of Good And Poor Responders To Chemoradiotherapy: A Rectal Cancer Multicentre Randomised Control Trial not-yet-due
Other 2015-005525-39 Proof-of-concept study of ibrutinib in c-MYC and HER2 amplified gastrooesophageal carcinoma not-yet-due
Other 2016-003306-13 CCR 4557: Peri-operative Immuno-Chemotherapy in Operable oesophageal aNd gastrIc Cancer (ICONIC Trial) not-yet-due
Exempt 2016-005187-34 Stereotactic body radiotherapy with immunotherapy in early stage non-small cell lung cancer: tolerability and lung effects not-yet-due
Other 2017-000370-10 Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer: A phase III randomised study. not-yet-due
Other 2017-001680-20 Phase II study of ROS1 targeting with crizotinib in advanced E-cadherin negative, ER positive lobular breast cancer or diffuse gastric cancer not-yet-due
Other 2017-001770-42 A multicenter phase II non-randomised trial assessing the efficacy of Domatinostat plus avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorecta... not-yet-due
Other 2018-000454-22 A translational phase II study of single agent Olaparib in the treatment of advanced oesophagogastric cancer not-yet-due
Other 2018-002250-79 iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer. not-yet-due
Other 2018-004138-13 A multicentre phase II non-randomised trial assessing the efficacy of DKN-01 plus atezolizumab in patients with advanced mismatch repair proficient oesophagogastric cancer not-yet-due